Ftse Mib
33.762,25
-0,83%
DAX
18.720,01
-1,47%
S&P 500
5.702,55
-0,19%
NASDAQ
17.948,32
-0,36%
Bitcoin
62.921,39
-0,71%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Mind Medicine MindMed Inc (MNMD) Mind Medicine MindMed Inc (MNMD) Notizie

MNMD

Mind Medicine MindMed (MNMD)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MNMD
DataOraFonteTitoloSimboloCompagnia
09/09/202422:01Business WireMindMed Announces New Employee Inducement GrantsNASDAQ:MNMDMind Medicine MindMed Inc
04/09/202413:00Business WireMindMed to Participate in September Investor ConferencesNASDAQ:MNMDMind Medicine MindMed Inc
22/08/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
13/08/202413:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MNMDMind Medicine MindMed Inc
13/08/202413:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNMDMind Medicine MindMed Inc
13/08/202413:00Business WireMindMed Reports Second Quarter 2024 Financial Results and Business UpdatesNASDAQ:MNMDMind Medicine MindMed Inc
13/08/202411:45IH Market NewsU.S. Futures Climb Before Inflation Data; Oil Slips on OPEC Demand CutNASDAQ:MNMDMind Medicine MindMed Inc
12/08/202412:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MNMDMind Medicine MindMed Inc
09/08/202414:44Business WireMind Medicine (MindMed) Inc. Announces Pricing of Public OfferingNASDAQ:MNMDMind Medicine MindMed Inc
09/08/202412:00Business WireMind Medicine (MindMed) Inc. Announces Proposed Public OfferingNASDAQ:MNMDMind Medicine MindMed Inc
06/08/202422:01Business WireMindMed to Present at Canaccord Genuity’s 44th Annual Growth ConferenceNASDAQ:MNMDMind Medicine MindMed Inc
06/08/202413:00Business WireMindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business UpdateNASDAQ:MNMDMind Medicine MindMed Inc
29/07/202413:00Business WireMindMed Appoints Stephanie Fagan as Chief Corporate Affairs OfficerNASDAQ:MNMDMind Medicine MindMed Inc
17/07/202413:00Business WireMindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT)NASDAQ:MNMDMind Medicine MindMed Inc
28/06/202413:00Business WireMindMed to be Included in Russell 2000® and Russell 3000® IndexesNASDAQ:MNMDMind Medicine MindMed Inc
21/06/202413:00Business WireMindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual ConferenceNASDAQ:MNMDMind Medicine MindMed Inc
20/06/202413:00Business WireMindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)NASDAQ:MNMDMind Medicine MindMed Inc
28/05/202413:00Business WireMindMed to Participate in June ConferencesNASDAQ:MNMDMind Medicine MindMed Inc
09/05/202422:01Business WireMindMed to Participate at May Investor ConferencesNASDAQ:MNMDMind Medicine MindMed Inc
09/05/202414:00Business WireNew Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the USNASDAQ:MNMDMind Medicine MindMed Inc
08/05/202422:01Business WireMindMed Reports First Quarter 2024 Financial Results and Business UpdatesNASDAQ:MNMDMind Medicine MindMed Inc
04/05/202414:00Business WireMindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New YorkNASDAQ:MNMDMind Medicine MindMed Inc
02/05/202413:00Business WireMindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business UpdateNASDAQ:MNMDMind Medicine MindMed Inc
25/04/202413:00Business WireMindMed to Present at Upcoming May Medical ConferencesNASDAQ:MNMDMind Medicine MindMed Inc
02/04/202413:00Business WireMindMed to Present at Upcoming April Medical ConferencesNASDAQ:MNMDMind Medicine MindMed Inc
01/04/202423:00Business WireMindMed Announces Voluntary Delisting from Cboe CanadaNASDAQ:MNMDMind Medicine MindMed Inc
11/03/202412:00Business WireMindMed to Participate in the Leerink Partners 2024 Global Biopharma ConferenceNASDAQ:MNMDMind Medicine MindMed Inc
07/03/202413:13Business WireMind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private PlacementNASDAQ:MNMDMind Medicine MindMed Inc
07/03/202413:09Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:MNMDMind Medicine MindMed Inc
07/03/202412:00Business WireMindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety DisorderNASDAQ:MNMDMind Medicine MindMed Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MNMD

La tua Cronologia

NASDAQ
MMVWW
MultiMetaVerse
AMEX
MDYG
SPDR S&P 400 Mid Cap Gro...
LSE
MVR2
Marwyn Value Investors
ASX
SCUN
Stemcell United
NASDAQ
KYCHW
Keyarch Acquisition
NASDAQ
MB
MINDBODY, INC.
NYSE
HIMS
Hims and Hers Health
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network